PLoS ONE (Jan 2024)
Clinical factors associated with the therapeutic efficacy of atezolizumab plus bevacizumab in patients with unresectable hepatocellular carcinoma: A multicenter prospective observational study
- Machiko Kai,
- Hayato Hikita,
- Maesaka Kazuki,
- Yuki Tahata,
- Kazuma Shinkai,
- Akira Doi,
- Kazuyoshi Ohkawa,
- Masanori Miyazaki,
- Hisashi Ishida,
- Kengo Matsumoto,
- Yasutoshi Nozaki,
- Takayuki Yakushijin,
- Ryotaro Sakamori,
- Akira Kaneko,
- Sadaharu Iio,
- Takatoshi Nawa,
- Naruyasu Kakita,
- Naoki Morishita,
- Naoki Hiramatsu,
- Takeo Usui,
- Kazuho Imanaka,
- Yoshinori Doi,
- Mitsuru Sakakibara,
- Yuichi Yoshida,
- Tsugiko Oze,
- Takahiro Kodama,
- Tomohide Tatsumi,
- Tetsuo Takehara
Affiliations
- Machiko Kai
- Hayato Hikita
- Maesaka Kazuki
- Yuki Tahata
- Kazuma Shinkai
- Akira Doi
- Kazuyoshi Ohkawa
- Masanori Miyazaki
- Hisashi Ishida
- Kengo Matsumoto
- Yasutoshi Nozaki
- Takayuki Yakushijin
- Ryotaro Sakamori
- Akira Kaneko
- Sadaharu Iio
- Takatoshi Nawa
- Naruyasu Kakita
- Naoki Morishita
- Naoki Hiramatsu
- Takeo Usui
- Kazuho Imanaka
- Yoshinori Doi
- Mitsuru Sakakibara
- Yuichi Yoshida
- Tsugiko Oze
- Takahiro Kodama
- Tomohide Tatsumi
- Tetsuo Takehara
- Journal volume & issue
-
Vol. 19,
no. 1